Avicanna Inc

Avicanna Inc. has reported its first profitable quarter in Q1 2025, with revenue of $6.32 million and net income of $74,154, driven by strategic cost efficiencies and margin improvements.

Avicanna Inc. has reported its first profitable quarter in Q1 2025, with a net income of $74,154 and revenue of $6.32 million, driven by cost efficiencies and margin improvements.

Avicanna Inc. has achieved its first profitable quarter in Q1 2025, marking a significant milestone for the Toronto-based biopharmaceutical company and positioning it for sustained growth and innovation in the cannabinoid market.